BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260430T140000
DTEND;TZID=America/New_York:20260430T153000
DTSTAMP:20260428T022350
CREATED:20260422T141825Z
LAST-MODIFIED:20260427T175443Z
UID:3021-1777557600-1777563000@lifescievents.com
SUMMARY:Sagimet Biosciences - A Novel Mechanism of Action for Treating Acne: Update on the Planned Phase 3 Trial of Denifanstat for the Treatment of Moderate to Severe Acne for the US
DESCRIPTION:Join Sagimet Biosciences for a virtual event featuring key opinion leader (KOL) Julie Harper\, MD\, Founding Director and past President of the American Acne and Rosacea Society\, who will join company management to discuss the current acne treatment landscape and the unmet need for additional treatment options for moderate to severe acne vulgaris. \nManagement will discuss the planned Phase 3 clinical trial of denifanstat in moderate to severe acne for the U.S.\, expected to begin in the second half of 2026. Denifanstat is a once-daily oral small molecule fatty acid synthase (FASN) inhibitor with potential as a novel mechanism of action to address moderate to severe acne\, a condition that impacts more than 10 million people annually in the U.S. \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/ha9t02g/.
URL:https://lifescievents.com/event/ha9t02g/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/04/Sagimet-Banner-1.png
END:VEVENT
END:VCALENDAR